Logo image of FSRD

FAST RADIUS INC (FSRD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FSRD - US31187R1005 - Common Stock

0.14 USD
-0.07 (-33.33%)
Last: 11/17/2022, 8:19:18 PM
0.132 USD
-0.01 (-5.71%)
After Hours: 11/17/2022, 8:19:18 PM
Fundamental Rating

1

Taking everything into account, FSRD scores 1 out of 10 in our fundamental rating. FSRD was compared to 132 industry peers in the Machinery industry. FSRD has a bad profitability rating. Also its financial health evaluation is rather negative. FSRD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FSRD has reported negative net income.
In the past year FSRD has reported a negative cash flow from operations.
FSRD Yearly Net Income VS EBIT VS OCF VS FCFFSRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -181.77%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FSRD Yearly ROA, ROE, ROICFSRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 200 -200 400 600

1.3 Margins

Industry RankSector Rank
OM -391.8%
PM (TTM) -375.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FSRD Yearly Profit, Operating, Gross MarginsFSRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 0 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

FSRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FSRD remains at a similar level compared to 1 year ago.
Compared to 1 year ago, FSRD has a worse debt to assets ratio.
FSRD Yearly Shares OutstandingFSRD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 20M 40M 60M
FSRD Yearly Total Debt VS Total AssetsFSRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 10M 20M 30M 40M

2.2 Solvency

FSRD has an Altman-Z score of -9.90. This is a bad value and indicates that FSRD is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.40 indicates that FSRD is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z -9.9
ROIC/WACCN/A
WACC7.69%
FSRD Yearly LT Debt VS Equity VS FCFFSRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 20M -20M -40M

2.3 Liquidity

A Current Ratio of 1.13 indicates that FSRD should not have too much problems paying its short term obligations.
FSRD has a Quick Ratio of 1.12. This is a normal value and indicates that FSRD is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.12
FSRD Yearly Current Assets VS Current LiabilitesFSRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

FSRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -213.24%.
Looking at the last year, FSRD shows a very strong growth in Revenue. The Revenue has grown by 43.29%.
EPS 1Y (TTM)-213.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.85%
Revenue 1Y (TTM)43.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%49.48%

3.2 Future

Based on estimates for the next years, FSRD will show a decrease in Earnings Per Share. The EPS will decrease by -8.87% on average per year.
The Revenue is expected to grow by 39.63% on average over the next years. This is a very strong growth
EPS Next Y-65.72%
EPS Next 2Y-8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year45.45%
Revenue Next 2Y39.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

FSRD Yearly Revenue VS EstimatesFSRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M
FSRD Yearly EPS VS EstimatesFSRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FSRD. In the last year negative earnings were reported.
Also next year FSRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FSRD Price Earnings VS Forward Price EarningsFSRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.01
FSRD Per share dataFSRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

A cheap valuation may be justified as FSRD's earnings are expected to decrease with -8.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.87%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FSRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FAST RADIUS INC

NASDAQ:FSRD (11/17/2022, 8:19:18 PM)

After market: 0.132 -0.01 (-5.71%)

0.14

-0.07 (-33.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-11 2022-08-11/bmo
Earnings (Next)12-15 2022-12-15/bmo
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners34.87%
Ins Owner Change0%
Market Cap10.57M
Revenue(TTM)33.55M
Net Income(TTM)-126.02M
Analysts82.86
Price Target3.06 (2085.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-15.34%
Max EPS beat(2)5.23%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)11.44%
Min Revenue beat(2)11.44%
Max Revenue beat(2)11.44%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA -0.01
EPS(TTM)-1.75
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)-1.16
OCFYN/A
SpS0.44
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -181.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -391.8%
PM (TTM) -375.62%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 354.13%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.12
Altman-Z -9.9
F-Score3
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-213.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.85%
EPS Next Y-65.72%
EPS Next 2Y-8.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%49.48%
Revenue Next Year45.45%
Revenue Next 2Y39.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-185.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-20.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-165.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-133.31%
OCF growth 3YN/A
OCF growth 5YN/A

FAST RADIUS INC / FSRD FAQ

Can you provide the ChartMill fundamental rating for FAST RADIUS INC?

ChartMill assigns a fundamental rating of 2 / 10 to FSRD.


Can you provide the valuation status for FAST RADIUS INC?

ChartMill assigns a valuation rating of 3 / 10 to FAST RADIUS INC (FSRD). This can be considered as Overvalued.


What is the profitability of FSRD stock?

FAST RADIUS INC (FSRD) has a profitability rating of 1 / 10.


How financially healthy is FAST RADIUS INC?

The financial health rating of FAST RADIUS INC (FSRD) is 2 / 10.